AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Massachusetts

H2506

Decriminalizing psilocybin as a treatment for PTSD and certain other conditions

Status

Pending

2026 Session

IntroducedFeb 27, 2025 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Steven Owens (Democrat)
Type: Decriminalization
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Relative to psilocybin as a treatment for PTSD and certain other conditions. Public Health.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: malegislature.gov

Legislative history

January 28, 2026
Accompanied a new draft, see H4986
February 27, 2025
Referred
February 27, 2025
Introduced

Loading bill…